DermTech 2.0 provides genomic analysis of skin samples collected non-invasively using its proprietary Smart Sticker platform technology. DermTech 2.0 develops and markets products to facilitate the assessment of melanoma, including the DermTech Melanoma Test, and offers DermTech Stratum, a precision biomarker service offering for biopharmaceutical and research partners.
Looking for a particular DermTech employee's phone or email?
The DermTech annual revenue was $15.7 million in 2026.
Kevin Sun is the Chief Financial Officer, Treasurer, Secretary of DermTech.
54 people are employed at DermTech.
DermTech is based in San Diego, California.
The NAICS codes for DermTech are [54, 33, 62151, 541, 621, 62, 6215].
The SIC codes for DermTech are [87, 38, 384].